Inflamación y Daño Vascular en la Enfermedad Renal Crónica, Diálisis y Trasplante Renal. Fisiopatología renal

Macias, N; Goicoechea, M; de Vinuesa, MSG; Verdalles, U; Luno, J.

Urate Reduction and Renal Preservation: What Is the Evidence?

Current Rheumatology Reports. 2013; 15(12): Nº de citas: 4 [doi:10.1007/s11926-013-0386-3]

Fernandez-Juarez, G; Luno, J; Barrio, V; de Vinuesa, SG; Praga, M; Goicoechea, M; Lahera, V; Casas, L; Oliva, J.

25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2013; 8(11): 1870-1876 Nº de citas: 89 [doi:10.2215/CJN.00910113]

Rojas, L; Munoz, P; Kestler, M; Arroyo, D; Guembe, M; Rodriguez-Creixems, M; Verde, E; Bouza, E.

Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality

JOURNAL OF HOSPITAL INFECTION. 2013; 85(3): 196-205 Nº de citas: 34 [doi:10.1016/j.jhin.2013.07.009]

Yuste, C; De Vinuesa, SG; Goicoechea, M; Barraca, D; Panizo, N; Quiroga, B; Luno, J.

Vitamin D deficiency in a Spanish cohort of patients with chronic kidney disease

MEDICINA CLINICA. 2013; 141(8): 338-342 Nº de citas: 5 [doi:10.1016/j.medcli.2012.07.026]

Fermoselle, C; Garcia-Arumi, E; Puig-Vilanova, E; Andreu, AL; Urtreger, AJ; Joffe, EDBD; Tejedor, A; Puente-Maestu, L; Barreiro, E.

Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice

EXP PHYSIOL. 2013; 98(9): 1349-1365 Nº de citas: 62 [doi:10.1113/expphysiol.2013.072496]

Panizo, N; Rivera, F; Lopez-Gomez, JM.

Decreasing incidence of AA amyloidosis in Spain

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2013; 43(8): 767-773 Nº de citas: 16 [doi:10.1111/eci.12097]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Bellon-Cano, JM; Sanjurjo-Saez, M.

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

International Journal of Clinical Pharmacy. 2013; 35(3): 463-468 Nº de citas: 5 [doi:10.1007/s11096-013-9774-z]

Puente-Maestu, L; Lazaro, A; Humanes, B.

Metabolic derangements in COPD muscle dysfunction

J APPL PHYSIOL. 2013; 114(9): 1282-1290 Nº de citas: 25 [doi:10.1152/japplphysiol.00815.2012]

Lledo-Garcia, E; Humanes-Sanchez, B; Mojena-Sanchez, M; Rodrigez, JCJ; Hernandez-Fernandez, C; Tejedor-Jorge, A; Fernandez, AL.

Independent Cellular Effects of Cold Ischemia and Reperfusion: Experimental Molecular Study

TRANSPLANTATION PROCEEDINGS. 2013; 45(3): 1260-1263 Nº de citas: 1 [doi:10.1016/j.transproceed.2013.02.034]

Escudero-Vilaplana, V; Martinez-Nieto, C; Lopez-Gomez, JM; Vega-Martinez, A; Sanjurjo-Saez, M.

Equipotent Doses of Erythropoiesis-Stimulating Agents in Outpatients with Anaemia Secondary to Chronic Kidney Disease

LATIN AMERICAN JOURNAL OF PHARMACY. 2013; 32(3): 454-458

Quiroga, B; Verde, E; Abad, S; Vega, A; Goicoechea, M; Reque, J; Lopez-Gomez, JM; Luno, J.

Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis

JOURNAL OF SURGICAL RESEARCH. 2013; 180(1): 51-55 Nº de citas: 34 [doi:10.1016/j.jss.2012.10.008]

Juarez, GF; Luno, J; Barrio, V; de Vinuesa, SG; Praga, M; Goicoechea, M; Cachofeiro, V; Nieto, J; Vega, FF; Tato, A; Gutierrez, E.

Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial

AMERICAN JOURNAL OF KIDNEY DISEASES. 2013; 61(2): 211-218 Nº de citas: 72 [doi:10.1053/j.ajkd.2012.07.011]

Locatelli, F; Hannedouche, T; Martin-Malo, A; Jacobson, SH; Vanholder, R; Ronco, C; La Milia, V; Gomez, JML; Stefoni, S; Maheut, H; Klinger, M; Krummel, T; Dhondt, A; Berdud, I; Gauly, A.

The Relationship of NT-proBNP and Dialysis Parameters with Outcome of Incident Haemodialysis Patients: Results from the Membrane Permeability Outcome Study

BLOOD PURIFICATION. 2013; 35(1-3): 216-223 Nº de citas: 12 [doi:10.1159/000347076]

Yuste, C; Barraca, D; Aragoncillo-Sauco, I; Vega-Martinez, A; Abad, S; Verdalles-Guzman, U; Ruiz-Caro, C; Ampuero, J; Lopez-Gomez, JM.

Factors related with the progression of chronic kidney disease

NEFROLOGIA. 2013; 33(5): 685-691 Nº de citas: 14 [doi:10.3265/Nefrologia.pre2013.May.11900]

Palomares, I; Ramos, R; Martin-Malo, A; Merello, JI; Praga, M; Luno, J; de Francisco, ALM.

Compliance with Mineral Metabolism Targets in Haemodialysis Patients: Moving Backwards?

BLOOD PURIFICATION. 2013; 36(2): 122-131 Nº de citas: 8 [doi:10.1159/000353418]

Quiroga, B; Villaverde, M; Abad, S; Vega, A; Reque, J; Lopez-Gomez, JM.

Diastolic Dysfunction and High Levels of New Cardiac Biomarkers as Risk Factors for Cardiovascular Events and Mortality in Hemodialysis Patients

BLOOD PURIFICATION. 2013; 36(2): 98-106 Nº de citas: 15 [doi:10.1159/000354080]

Praga, M; Merello, JI; Palomares, I; Bayh, I; Marcelli, D; Aljama, P; Luno, J.

Type of Vascular Access and Survival among Very Elderly Hemodialysis Patients

NEPHRON CLIN PRACT. 2013; 124(1-2): 47-53 Nº de citas: 28 [doi:10.1159/000355694]

Herrero, JA; Lopez-Gomez, JM; Maduell, F; Martin-de Francisco, AL; Martin-Malo, A; Martinez-Castelao, A; Navarro-Gonzalez, JF; Perez-Fontan, M; Perez, J; Selgas, R; Solozabal, C.

Activation of vitamin D receptors in the optimization of hyperparathyroidism secondary to dialysis

NEFROLOGIA. 2013; 33(4): 571-584 Nº de citas: 1 [doi:10.3265/Nefrologia.pre2013.May.11901]